Your Messages Inbox
Your Article Summary
See Latest ArticlesAllos Therapeutics Announces Closing of Public Offering
Allos Therapeutics, 10/14/09
Allos Therapeutics, Inc. announced the closing of its previously announced underwritten public offering of 14,000,000 shares of newly issued common stock at a public offering price of $7.10 per share. The Company received net proceeds from the sale of the shares, after underwriting discounts, commissions and estimated offering expenses, of approximately $93.0 million.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09
Taro Provides Preliminary Third Quarter and Year-to-Date 2009 Financial Results
Taro Pharmaceuticals USA, 12/03/09
IMS Predicts 4% to 6% Global Pharma Market Growth Next Year
U.S. Pharmacist, 12/02/09
Article Search
Sponsor